Non-coding RNA in osteoarthritis: mechanistic insights and future perspectives - Takeaways - MDSpire

Non-coding RNA in osteoarthritis: mechanistic insights and future perspectives

  • By

  • Manali Jain

  • Anamika Kumari Anuja

  • Soniya Yadav

  • Jasmin Ara

  • Anukool Ojha

  • Chandra Prakash Chaturvedi

  • July 14, 2026

Share

  • 1

    Non-coding RNAs (ncRNAs) are critical regulators of osteoarthritis (OA) pathogenesis, influencing gene expression at various levels.

  • 2

    MicroRNAs (miRNAs), particularly miR-140-5p, play significant roles in cartilage protection and modulate key biological processes in OA.

  • 3

    Long non-coding RNAs (lncRNAs) and circular RNAs (circRNAs) have limited validation in primary human OA tissues compared to miRNAs.

  • 4

    Circulating ncRNAs show potential as minimally invasive biomarkers for OA, although current studies face methodological challenges.

  • 5

    NcRNA-based therapeutics demonstrate promise in preclinical models of OA, but face challenges in delivery efficiency and clinical translation.

Original Source(s)

Non-coding RNA in osteoarthritis: mechanistic insights and future perspectives

  • by Manali Jain, Anamika Kumari Anuja, Soniya Yadav, Jasmin Ara, Anukool Ojha, Chandra Prakash Chaturvedi

  • July 14, 2026

Related Content

May Ultraprocessed Foods Raise Muscle Fat?

MRI study suggests higher intake is associated with greater intramuscular fat in patients at risk for knee osteoarthritis.

Antibiotic Falls Short in Disc-Related Back Pain

A randomized trial found no greater pain reduction vs placebo, but questions remain about patients with type 1 Modic changes.

Inflammaging and osteoarthritis - therapeutic opportunities